BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 14098188)

  • 1. THE EXCHANGE OF 14CO2 WITH BRANCHED-CHAIN KETOACIDS BY GUINEA-PIG LIVER.
    DANCIS J; HUTZLER J; LEVITZ M
    Biochim Biophys Acta; 1963 Oct; 78():90-3. PubMed ID: 14098188
    [No Abstract]   [Full Text] [Related]  

  • 2. THE DIAGNOSIS OF MAPLE SYRUP URINE DISEASE (BRANCHED- CHAIN KETOACIDURIA) BY THE IN VITRO STUDY OF THE PERIPHERAL LEUKOCYTE.
    DANCIS J; HUTZLER J; LEVITZ M
    Pediatrics; 1963 Aug; 32():234-8. PubMed ID: 14044451
    [No Abstract]   [Full Text] [Related]  

  • 3. [CLINICAL, BIOCHEMICAL, AND NEUROPATHOLOGIC ASPECTS OF MAPLE SYRUP URINE DISEASE. A KETOACIDURIA OF THE OPEN CHAIN AMINOACIDS LEUCINE, ISOLEUCINE AND VALINE].
    SILBERMANSCHWARTZMAN J
    An Fac Med Lima; 1963 Sep; 46():339-65. PubMed ID: 14122039
    [No Abstract]   [Full Text] [Related]  

  • 4. Maple syrup urine disease: branched-chain amino acid concentrations and metabolism in cultured human lymphoblasts.
    Skaper SD; Molden DP; Seegmiller JE
    Biochem Genet; 1976 Aug; 14(7-8):527-39. PubMed ID: 985377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidation of leucine, isoleucine and related ketoacids in developing rabbit brain.
    Swaiman KF; Milstein JM
    J Neurochem; 1965 Dec; 12(12):981-6. PubMed ID: 5892498
    [No Abstract]   [Full Text] [Related]  

  • 6. [Acrodermatitis enteropathica-like syndrome secondary to branched-chain amino acid deficiency during treatment of maple syrup urine disease].
    Templier I; Reymond JL; Nguyen MA; Boujet C; Lantuejoul S; Beani JC; Leccia MT
    Ann Dermatol Venereol; 2006 Apr; 133(4):375-9. PubMed ID: 16733455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition by the branched-chain 2-oxo acids of the 2-oxoglutarate dehydrogenase complex in developing rat and human brain.
    Patel MS
    Biochem J; 1974 Oct; 144(1):91-7. PubMed ID: 4462577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma amino acid analyses in two cases of maple syrup urine disease.
    Surarit R; Srisomsap C; Wasant P; Svasti J; Suthatvoravut U; Chokchaichamnankit D; Liammongkolkul S
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():138-9. PubMed ID: 11400750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme activity in classical and variant forms of maple syrup urine disease.
    Dancis J; Hutzler J; Snyderman SE; Cox RP
    J Pediatr; 1972 Aug; 81(2):312-20. PubMed ID: 5042489
    [No Abstract]   [Full Text] [Related]  

  • 10. Blood and tissue branched-chain amino and alpha-keto acid concentrations: effect of diet, starvation, and disease.
    Hutson SM; Harper AE
    Am J Clin Nutr; 1981 Feb; 34(2):173-83. PubMed ID: 7211722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolongation of G1 and S phase in C-6 glioma cells treated with maple syrup urine disease metabolits. Morphologic and cell cycle studies.
    Liao CL; Herman MM; Bensch KG
    Lab Invest; 1978 Feb; 38(2):122-33. PubMed ID: 564423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DIETARY TREATMENT OF A CHILD WITH MAPLE SYRUP URINE DISEASE (BRANCHED-CHAIN KETOACIDURIA).
    WESTALL RG
    Arch Dis Child; 1963 Oct; 38(201):485-91. PubMed ID: 14065992
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical characteristics and analysis of mass spectrometric data in 33 patients with maple syrup urine disease].
    Yang N; Han LS; Ye J; Qiu WJ; Zhang HW; Gao XL; Wang Y; Li XY; Xu H; Gu XF
    Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(40):2839-42. PubMed ID: 23290213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LATE MANIFESTING VARIANT OF BRANCHED-CHAIN KETOACIDURIA (MAPLE SYRUP URINE DISEASE).
    KIIL R; ROKKONES T
    Acta Paediatr (Stockh); 1964 Jul; 53():356-64. PubMed ID: 14184314
    [No Abstract]   [Full Text] [Related]  

  • 15. Biochemical studies on a variant of branched chain ketoaciduria in a 19-year-old female.
    Fischer MH; Gerritsen T
    Pediatrics; 1971 Nov; 48(5):795-801. PubMed ID: 5125877
    [No Abstract]   [Full Text] [Related]  

  • 16. The relationship between the branched chain amino acids and their alpha-ketoacids in maple syrup urine disease.
    Snyderman SE; Goldstein F; Sansaricq C; Norton PM
    Pediatr Res; 1984 Sep; 18(9):851-3. PubMed ID: 6483508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAPLE SYRUP URINE DISEASE: A MANIFESTATION OF AN UNUSUAL METABOLIC ERROR.
    DANCIS J
    Clin Pediatr (Phila); 1964 Jun; 3():365-7. PubMed ID: 14154327
    [No Abstract]   [Full Text] [Related]  

  • 18. The need of essential amino acids in children. An evaluation based on the intake of phenylalanine, tyrosine, leucine, isoleucine, and valine in children with phenylketonuria, tyrosine amino transferase defect, and maple syrup urine disease.
    Kindt E; Halvorsen S
    Am J Clin Nutr; 1980 Feb; 33(2):279-86. PubMed ID: 6101930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maple syrup urine disease (branched-chain keto-aciduria) variant type manifesting as hyperkinetic behaviour and mental retardation. Report of two cases.
    Kalyanaraman K; Chamukuttan S; Arjundas G; Gajanan N; Ramamurthi B
    J Neurol Sci; 1972 Feb; 15(2):209-17. PubMed ID: 5010106
    [No Abstract]   [Full Text] [Related]  

  • 20. Classical maple syrup urine disease: cofactor resistance.
    Elsas LJ; Pask BA; Wheeler FB; Perl DP; Truster S
    Metabolism; 1972 Oct; 21(10):929-44. PubMed ID: 4342010
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.